Eesti - eesti - Ravimiamet

galex d.d. - irbesartaan - õhukese polümeerikattega tablett - 300mg 90tk; 300mg 28tk; 300mg 30tk; 300mg 56tk; 300mg 84tk; 300mg 14tk

Eesti - eesti - Ravimiamet

portfarma ehf. - sildenafiil - närimistablett - 50mg 2tk; 50mg 1tk; 50mg 12tk; 50mg 8tk

Eesti - eesti - Ravimiamet

fairmed healthcare gmbh - montelukast - närimistablett - 4mg 28tk; 4mg 50tk; 4mg 56tk; 4mg 200tk; 4mg 10tk; 4mg 20tk; 4mg 14tk; 4mg 7tk; 4mg 100tk

Eesti - eesti - Ravimiamet

pharmaswiss ceska republika s.r.o. - memantiin - suus dispergeeruv tablett - 5mg 30tk; 5mg 28tk; 5mg 56tk

Eesti - eesti - Ravimiamet

fairmed healthcare gmbh - montelukast - õhukese polümeerikattega tablett - 10mg 100tk; 10mg 84tk; 10mg 56tk; 10mg 98tk; 10mg 200tk; 10mg 20tk; 10mg 140tk; 10mg 50tk; 10mg 90tk; 10mg 28tk; 10mg 30tk; 10mg 14tk; 10mg 7tk

Eesti - eesti - Ravimiamet

portfarma ehf. - sildenafiil - närimistablett - 25mg 1tk; 25mg 8tk; 25mg 12tk; 25mg 4tk

Eesti - eesti - Ravimiamet

teva pharma b.v. - sildenafiil - närimistablett - 100mg 2tk; 100mg 12tk; 100mg 24tk; 100mg 28tk; 100mg 8tk; 100mg 4tk

Eesti - eesti - Ravimiamet

pharmaswiss ceska republika s.r.o. - memantiin - suus dispergeeruv tablett - 15mg 98tk; 15mg 28tk; 15mg 30tk

Eesti - eesti - Ravimiamet

mylan ireland limited - posakonasool - suukaudne suspensioon - 40mg 1ml 105ml 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.